Evaxion completes phase 2 cancer vaccine trial extension

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Evaxion completes phase 2 cancer vaccine trial extension
(NASDAQ: EVAX) Delayed: 3.39 -0.03 (0.88%)
Previous Close $3.42    52 Week High $ 
Open $3.40    52 Week Low $ 
Day High $3.60    P/E N/A 
Day Low $3.38    EPS $ 
Volume 11,474